/4893.T
4893.T Stock - Noile-Immune Biotech Inc.
Healthcare|BiotechnologyJPX
$133.00+0.76%
+$1.00 (+0.76%) • Dec 24
57
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.9
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $146.30
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4893.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$131.67 – $134.33
TARGET (TP)$152.95
STOP LOSS$122.36
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.64
52W High$229.00
52W Low$120.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $7.59M | $316.82M | $625.78M | $100.73M | $97.28M |
| Gross Profit | $7.39M | $314.56M | $618.71M | $77.83M | $94.31M |
| Gross Margin | 97.4% | 99.3% | 98.9% | 77.3% | 96.9% |
| Operating Income | $-1,069,183,000 | $-775,391,000 | $-106,345,000 | $-767,511,000 | $-604,477,000 |
| Net Income | $-964,455,000 | $-1,130,014,000 | $-386,622,000 | $-795,035,000 | $-636,649,000 |
| Net Margin | -12711.9% | -356.7% | -61.8% | -789.3% | -654.5% |
| EPS | $-22.26 | $-27.25 | $-9.87 | $-19.33 | $-15.48 |
Company Overview
Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4893.TBeat Rate
67%
Last 3 quarters
Avg Surprise
+8.3%
EPS vs Estimate
Beats / Misses
2/1
Last 12 quarters
Latest EPS
$-4.46
Q4 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
-115.2%
$-2.40vs$15.79
Q1 25
+80.4%
$-4.09vs$-20.87
Q2 25
No data
Q4 25
+59.6%
$-4.46vs$-11.04
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | $-11.04 | $-4.46 | +59.6% | ✓ BEAT |
Q2 2025 | May 12, 2025 | — | $-5.55 | — | — |
Q1 2025 | Feb 14, 2025 | $-20.87 | $-4.09 | +80.4% | ✓ BEAT |
Q4 2024 | Nov 14, 2024 | $15.79 | $-2.40 | -115.2% | ✗ MISS |
Q3 2024 | Aug 9, 2024 | — | $-7.93 | — | — |
Q2 2024 | May 14, 2024 | — | $-7.86 | — | — |
Q1 2024 | Feb 13, 2024 | — | $-6.46 | — | — |
Q4 2023 | Nov 13, 2023 | — | $-0.39 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-8.54 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-11.27 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-10.56 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 4893.T
What is 4893.T's current stock price?
Noile-Immune Biotech Inc. (4893.T) is currently trading at $133.00 per share. The stock has moved +0.76% today.
What is the analyst price target for 4893.T?
No analyst price targets are currently available for this stock.
What sector is Noile-Immune Biotech Inc. in?
Noile-Immune Biotech Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the JPX exchange.
What is 4893.T's market cap?
Noile-Immune Biotech Inc. has a market capitalization of $5.76 billion, making it a mid-cap company.
Does 4893.T pay dividends?
No, Noile-Immune Biotech Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector177A.T
Kohjin Bio Co., Ltd.
$1461.00
Mkt Cap: $7.5B
206A.T
PRISM BioLab Co.,LTD
$148.00
Mkt Cap: $5.4B
2183.T
Linical Co., Ltd.
$293.00
Mkt Cap: $6.6B
3750.T
ADR120S, Inc.
$825.00
Mkt Cap: $7.4B
4564.T
OncoTherapy Science, Inc.
$21.00
Mkt Cap: $7.1B
4583.T
Chiome Bioscience Inc.
$108.00
Mkt Cap: $7.3B
4586.T
MedRx Co., Ltd
$111.00
Mkt Cap: $6.4B
4594.T
BrightPath Biotherapeutics Co., Ltd.
$46.00
Mkt Cap: $4.3B
4891.T
TMS Co., Ltd.
$127.00
Mkt Cap: $5.8B
4896.T
K Pharma,Inc.
$638.00
Mkt Cap: $7.4B
Explore stocks similar to 4893.T for comparison